- Home
- MNSB vs NKTR Comparison
MNSB vs NKTR Comparison
Compare MNSB & NKTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNSB
- NKTR
- Stock Information
- Founded
- MNSB 2003
- NKTR 1990
- Country
- MNSB United States
- NKTR United States
- Employees
- MNSB N/A
- NKTR N/A
- Industry
- MNSB Major Banks
- NKTR Biotechnology: Pharmaceutical Preparations
- Sector
- MNSB Finance
- NKTR Health Care
- Exchange
- MNSB Nasdaq
- NKTR Nasdaq
- Market Cap
- MNSB 140.7M
- NKTR 125.5M
- IPO Year
- MNSB N/A
- NKTR 1994
- Fundamental
- Price
- MNSB $18.30
- NKTR $8.51
- Analyst Decision
- MNSB
- NKTR Strong Buy
- Analyst Count
- MNSB 0
- NKTR 6
- Target Price
- MNSB N/A
- NKTR $73.75
- AVG Volume (30 Days)
- MNSB 23.4K
- NKTR 348.5K
- Earning Date
- MNSB 07-28-2025
- NKTR 08-07-2025
- Dividend Yield
- MNSB 2.17%
- NKTR N/A
- EPS Growth
- MNSB N/A
- NKTR N/A
- EPS
- MNSB N/A
- NKTR N/A
- Revenue
- MNSB $59,896,000.00
- NKTR $87,248,000.00
- Revenue This Year
- MNSB $17.95
- NKTR N/A
- Revenue Next Year
- MNSB $2.52
- NKTR N/A
- P/E Ratio
- MNSB N/A
- NKTR N/A
- Revenue Growth
- MNSB N/A
- NKTR N/A
- 52 Week Low
- MNSB $15.00
- NKTR $6.48
- 52 Week High
- MNSB $20.88
- NKTR $22.79
- Technical
- Relative Strength Index (RSI)
- MNSB 45.27
- NKTR 42.19
- Support Level
- MNSB $18.00
- NKTR $7.99
- Resistance Level
- MNSB $18.52
- NKTR $9.71
- Average True Range (ATR)
- MNSB 0.46
- NKTR 1.37
- MACD
- MNSB -0.07
- NKTR -0.20
- Stochastic Oscillator
- MNSB 24.65
- NKTR 11.66
About MNSB MainStreet Bancshares Inc.
MainStreet Bancshares Inc is a bank holding company. It is focused on serving the borrowing, cash management and depository needs of small to medium-sized businesses, and professional practices and retail customers. The bank's products and services include business and consumer checking, premium interest-bearing checking, business account analysis, savings, certificates of deposit and other depository services, as well as a broad array of commercial, real estate and consumer loans.
About NKTR Nektar Therapeutics
Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the field of immunotherapy. Its pipeline products are REZPEG (NKTR-358), REZPEG (NKTR-358), REZPEG (NKTR-358), NKTR-422, NKTR-0165, NKTR-255, and Others.